GNRH1 and polycystic ovary syndrome: A recent clinical randomized controlled study, comparing the outcomes of GnRH-antagonist and GnRH-agonist protocols in patients without PCOS, demonstrated that the number of oocytes retrieved significantly influenced the CLBR in both protocols.